LianBio
NASDAQ:LIAN
0.319 (USD) • At close April 3, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 |
| Cost of Revenue
| 1.005 | 0.526 | 0.076 | 0 |
| Gross Profit
| -1.005 | -0.526 | -0.076 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 59.755 | 158.692 | 120.885 | 22.663 |
| General & Administrative Expenses
| 65.598 | 36.878 | 13.984 | 0.004 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 1.712 |
| SG&A
| 65.598 | 36.878 | 13.984 | 1.716 |
| Other Expenses
| 10.409 | -0.455 | 0.123 | 0 |
| Operating Expenses
| 125.353 | 195.57 | 134.869 | 24.379 |
| Operating Income
| -125.353 | -195.57 | -134.869 | -24.379 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 14.73 | -0.212 | -4.731 | 0.01 |
| Income Before Tax
| -110.623 | -195.782 | -139.6 | -24.369 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.333 | 0.518 | 0.004 | 0.004 |
| Net Income
| -110.29 | -196.3 | -139.604 | -24.373 |
| Net Income Ratio
| 0 | 0 | 0 | 0 |
| EPS
| -1.02 | -5.71 | -1.33 | -0.23 |
| EPS Diluted
| -1.02 | -5.71 | -1.33 | -0.23 |
| EBITDA
| -125.353 | -195.57 | -134.793 | -24.379 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 |